rs750088530
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_080605.4(B3GALT6):c.353delA(p.Asp118AlafsTer160) variant causes a frameshift change. The variant allele was found at a frequency of 0.000011 in 1,269,262 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D118D) has been classified as Likely benign.
Frequency
Consequence
NM_080605.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndrome, spondylodysplastic type, 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
- spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fracturesInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spondyloepimetaphyseal dysplasia with joint laxityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| B3GALT6 | NM_080605.4 | c.353delA | p.Asp118AlafsTer160 | frameshift_variant | Exon 1 of 1 | ENST00000379198.5 | NP_542172.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| B3GALT6 | ENST00000379198.5 | c.353delA | p.Asp118AlafsTer160 | frameshift_variant | Exon 1 of 1 | 6 | NM_080605.4 | ENSP00000368496.2 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150212Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000257 AC: 2AN: 77788 AF XY: 0.0000223 show subpopulations
GnomAD4 exome AF: 0.0000107 AC: 12AN: 1119050Hom.: 0 Cov.: 30 AF XY: 0.0000112 AC XY: 6AN XY: 535372 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150212Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 73282 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Frameshift variant predicted to result in abnormal protein length as the last 212 amino acids are replaced with 159 different amino acids, and other similar variants have been reported in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23664117, 31614862) -
Ehlers-Danlos syndrome, spondylodysplastic type, 2 Pathogenic:1
- -
Spondyloepimetaphyseal dysplasia with joint laxity;C3809210:Ehlers-Danlos syndrome, spondylodysplastic type, 2 Uncertain:1
This sequence change creates a premature translational stop signal (p.Asp118Alafs*160) in the B3GALT6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 212 amino acid(s) of the B3GALT6 protein. This variant is present in population databases (rs750088530, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with B3GALT6-related conditions (PMID: 23664117, 31614862). ClinVar contains an entry for this variant (Variation ID: 60490). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at